Skip to main content

Advertisement

Table 2 Treatment outcomes for amodiaquine plus sulphadoxine-pyrimethamine against P. falciparum malaria in Papua New Guinea

From: The usefulness of twenty-four molecular markers in predicting treatment outcome with combination therapy of amodiaquine plus sulphadoxine-pyrimethamine against falciparum malaria in Papua New Guinea

  Study sites
  Karimui area South Wosera area
  n = 80 n = 94
Outcome* Number (%)
ACPR 57 (71.2) 74 (81.3)
ETF 1 (1.3) 5 (5.5)
LCF 6 (7.5) 1 (1.1)
LPF 16 (20.0) 11 (12.1)
Total TF 23 (28.8) 17 (18.7)
  1. * PCR-corrected values up to Day 28; ACPR, Adequate clinical and parasitological response; ETF, Early treatment failure; LCF, Late clinical failure; LPF, Late parasitological failure; TF, Treatment failure